A detailed history of Newman Dignan & Sheerar, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 4,513 shares of DHR stock, worth $1.1 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
4,513
Previous 4,513 -0.0%
Holding current value
$1.1 Million
Previous $1.13 Million 0.09%
% of portfolio
0.29%
Previous 0.3%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$224.58 - $256.19 $279,602 - $318,956
-1,245 Reduced 21.62%
4,513 $1.13 Million
Q4 2023

Feb 08, 2024

SELL
$185.1 - $233.13 $8,514 - $10,723
-46 Reduced 0.79%
5,758 $1.33 Million
Q3 2023

Nov 07, 2023

SELL
$233.08 - $265.59 $102,555 - $116,859
-440 Reduced 7.05%
5,804 $1.44 Million
Q2 2023

Aug 02, 2023

SELL
$224.99 - $256.14 $13,499 - $15,368
-60 Reduced 0.95%
6,244 $1.5 Million
Q1 2023

Apr 28, 2023

SELL
$239.75 - $277.0 $5,993 - $6,925
-25 Reduced 0.4%
6,304 $1.59 Million
Q4 2022

Jan 20, 2023

SELL
$241.42 - $282.29 $12,795 - $14,961
-53 Reduced 0.83%
6,329 $0
Q2 2022

Aug 03, 2022

SELL
$237.11 - $299.66 $15,412 - $19,477
-65 Reduced 1.01%
6,382 $1.62 Million
Q1 2022

Apr 14, 2022

SELL
$257.27 - $315.76 $25,212 - $30,944
-98 Reduced 1.5%
6,447 $1.89 Million
Q4 2021

Jan 18, 2022

SELL
$292.08 - $329.01 $2,628 - $2,961
-9 Reduced 0.14%
6,545 $2.15 Million
Q3 2021

Oct 07, 2021

SELL
$272.21 - $332.43 $84,929 - $103,718
-312 Reduced 4.54%
6,554 $2 Million
Q2 2021

Jul 28, 2021

SELL
$225.08 - $271.69 $22,958 - $27,712
-102 Reduced 1.46%
6,866 $1.84 Million
Q1 2021

May 05, 2021

BUY
$212.38 - $245.9 $6,371 - $7,377
30 Added 0.43%
6,968 $1.57 Million
Q4 2020

Jan 29, 2021

SELL
$212.5 - $245.46 $6,375 - $7,363
-30 Reduced 0.43%
6,938 $1.54 Million
Q3 2020

Oct 14, 2020

BUY
$177.16 - $215.33 $67,497 - $82,040
381 Added 5.78%
6,968 $1.5 Million
Q2 2020

Aug 06, 2020

BUY
$128.7 - $176.83 $52,123 - $71,616
405 Added 6.55%
6,587 $1.33 Million
Q1 2020

Apr 20, 2020

SELL
$121.39 - $169.05 $34,717 - $48,348
-286 Reduced 4.42%
6,182 $944,000
Q3 2019

Oct 21, 2019

SELL
$135.4 - $146.47 $63,096 - $68,255
-466 Reduced 6.72%
6,468 $934,000
Q2 2019

Jul 31, 2019

SELL
$124.88 - $143.73 $37,464 - $43,119
-300 Reduced 4.15%
6,934 $991,000
Q1 2019

Apr 09, 2019

SELL
$97.62 - $132.29 $7,321 - $9,921
-75 Reduced 1.03%
7,234 $955,000
Q4 2018

Jan 24, 2019

BUY
$94.85 - $109.54 $26,083 - $30,123
275 Added 3.91%
7,309 $754,000
Q2 2018

Jul 06, 2018

SELL
$96.1 - $103.24 $7,207 - $7,743
-75 Reduced 1.06%
7,034 $694,000
Q1 2018

Apr 17, 2018

SELL
$92.16 - $103.8 $26,449 - $29,790
-287 Reduced 3.88%
7,109 $705,000
Q4 2017

Jan 29, 2018

SELL
$85.26 - $94.62 $6,223 - $6,907
-73 Reduced 0.98%
7,396 $686,000
Q2 2017

Aug 08, 2017

BUY
N/A
7,469
7,469 $630,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Newman Dignan & Sheerar, Inc. Portfolio

Follow Newman Dignan & Sheerar, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.